Ultrahuman Raises $60M Series C at $363M Valuation, Revenue Up 45%
创业邦 · wechat · 2026-09-04
Indian health-tech startup Ultrahuman raised a $60M Series C led by Qualcomm Ventures, with Labcorp, AlphaWave, Blume Ventures and others participating, at a $363M post-money valuation—triple its 2023 valuation.
- Founded in Bangalore in 2019, it started with CGM metabolic tracking; its core product is the Ring Air smart ring, which was banned from US import by the ITC over an Oura patent dispute. It returns in 2026 with the redesigned Ring Pro: dual-core processor with on-chip ML, up to 15 days battery, and 250 days of local health data storage
- Partnering with Qualcomm on next-gen rings with stronger local compute to reduce phone/cloud dependency
- Product suite spans CGM, blood biomarker testing, home sensors, plus Jade AI and the UltraSphere engine generating 60+ contextual health actions
- Financials: $68M operating revenue and $8.8M net profit for FY ending March 2025 (vs. a prior-year loss), $140M annualized revenue run rate, up 45% YoY
More from Venture
- Satirical Post: $1B 'AI Trading Lab' Allegedly Trades on Model-Release Insider Info — StewartalsopIII · 2026-10-20
- a16z's Ben Horowitz says AI buildout isn't the 90s bubble — an investor pushes back — henloitsjoyce · 2026-10-20
- DeepSeek hands inference providers 90%+ margins, pressuring Moonshot and Zhipu hosting deals — teortaxesTex · 2026-10-20
- a16z leads Eka Robotics Series A, betting on Vision-Force-Action models for dexterous manipulation — a16z · 2026-10-20
- Salesforce signs definitive agreement to acquire customer engagement platform Braze — thedealdirector · 2026-10-20
- Anthropic and OpenAI API gross margins claimed to be as high as 95% — zephyr_z9 · 2026-10-20